P360: Role of intestinal ultrasound scores in the diagnosis of post-operative recurrence in Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Amor Costa, C.(1)*;Suárez Ferrer , C.(1);Poza Cordón, J.(1);Yebra Carmona , J.(1);Rueda García , J.L.(1);Sánchez Azofra , M.(1);Martín Arranz, E.(1);González Díaz, I.(1);Amiama Roig, C.(1);Martín Arranz, M.D.(1);
(1)Hospital La Paz Institute for Health Research – IdiPAZ La Paz University Hospital – Universidad Autónoma de Madrid, Gastroenterology and Hepatology, Madrid, Spain;
P361: Risk of persistent gastrointestinal inflammation after treatment with immune checkpoint inhibitorsECCO’23 CopenhagenYear: 2023
Authors: Jeay, M.(1)*;Carbonnel, F.(1);Robert, C.(2);Bellanger, C.(1);Meyer, A.(1);
(1)Assistance Publique-Hôpitaux de Paris- Hôpital Bicêtre, Gastroenterology, Le Kremlin Bicêtre, France;(2)Institut Gustave Roussy, Dermatology unit- department of Medicine, Villejuif, France;
P362: Systematic review: Oncological outcomes of patients with Inflammatory Bowel Disease undergoing segmental colonic resections for colorectal cancer and dysplasiaECCO’23 CopenhagenYear: 2023
Authors: Shamsiddinova, A.(1,2)*;Deputy, M.(1);Worley, G.(1);Rao, C.(2,3);Dean, H.(1);Thomas-Gibson, S.(4,5);Faiz, O.(1,2);
(1)St Mark's Hospital, Colorectal Surgery, London, United Kingdom;(2)Imperial College London, Department of Surgery and Cancer, London, United Kingdom;(3)North Cumbria Integrated Care NHS Foundation Trust, Colorectal Surgery, Carlisle, United Kingdom;(4)St Mark's Hospital, Gastroenterology, London, United Kingdom;(5)Imperial College London, Department of Metabolism Digestion and Reproduction, London, United Kingdom;
P364: Presence of malnutrition adversely affects short-term clinical outcomes in a sample of patients with Crohn's disease (CD)ECCO’23 CopenhagenYear: 2023
Authors: Karachaliou, A.(1)*;Lekakis, V.(2);Bletsa, M.(3);Mantzaris, G.J.(4);Tzouvala, M.(5);Bamias, G.(6);Kontogianni, M.D.(1);
(1)Department of Nutrition & Dietetics- School of Health Sciences and Education, Harokopio University of Athens, Athens, Greece;(2)Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens- Laiko General Hospital, Athens, Greece;(3)Department of Nutrition and Dietetics, ‘'Sotiria'' Thoracic Diseases Hospital, Athens, Greece;(4)Department of Gastroenterology, ‘'Evangelismos-Ophthalmiatreion Athinon-Polykliniki'' General Hospital, Athens, Greece;(5)Department of Gastroenterology, General Hospital of Nikaia Piraeus “Agios Panteleimon”-General Hospital Dytikis Attikis “Agia Varvara”, Athens, Greece;(6)GI-Unit- 3rd Academic Department of Internal Medicine, “Sotiria'' Thoracic Diseases Hospital- Medical School- National and Kapodistrian University of Athens, Athens, Greece;
P366: genomics analysis and differentiation of Crohn's Disease, Intestinal Tuberculosis and Primary Intestinal IymphomaECCO’23 CopenhagenYear: 2023
Authors: Lin, L.(1)*;Qu, Y.(2);Zhao, X.(1);
(1)Southern Medical University, Nanfang Hospital, Guangzhou, China;(2)no, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China;
P367: Significant impact on health care utilization upon implementation of an electronic IBD care management program.ECCO’23 CopenhagenYear: 2023
Authors: Koppelman, L.(1)*;Roozemoind, S.(1);Cornelissen, L.(2);Hommes, D.(2);Voorneveld, P.(1);Maljaars, J.(1);Kubben, F.(3);Verweij, E.(3);van der Meulen - de Jong, A.(1);
(1)Leiden University Medical Centre, gastroenterology, Leiden, The Netherlands;(2)DEARhealth BV, DEARhealth, Amsterdam, The Netherlands;(3)Maasstad Ziekenhuis, gastroenterology, Rotterdam, The Netherlands;
P368: The presence of extra-intestinal manifestations is associated with poor prognosis in acute severe ulcerative colitis: A KASID multicenter studyECCO’23 CopenhagenYear: 2023
Authors: Kim, D.H.(1);Kim, E.S.(2);Kim, H.S.(3)*;Park, S.H.(4);Kim, S.J.(5);Kim, K.O.(6);Lee, Y.J.(7);Song, E.M.(8);Kim, D.S.(9);Lee, J.(5);
(1)Chonnam National University Hospital, Division of gastroenterology- Department of Internal medicine and Inflammatory Bowel disease Clinic, Gwnagju, Korea- Republic Of;(2)Kyungpook University Hospital, Department of Internal Medicine- Division of gastroenterology, Daegu, Korea- Republic Of;(3)Chonnam National University Hospital, Department of Internal Medicine- Division of gastroenterology, Gwangju, Korea- Republic Of;(4)Asan Medical Center, Department of Internal Medicine- Division of gastroenterology, Seoul, Korea- Republic Of;(5)Chosun University Hospital, Department of Internal Medicine- Division of Gastroenterology, Gwangju, Korea- Republic Of;(6)Yeungnam University Hospital, Department of Internal Medicine- Division of gastroenterology, Daegu, Korea- Republic Of;(7)Keimyung University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daegu, Korea- Republic Of;(8)Ewha Womans University Seoul Hospital, Department of Internal Medicine- Division of Gastroenterology, Seoul, Korea- Republic Of;(9)Konyang University Hospital, Department of Internal Medicine- Division of Gastroenterology, Daejeon, Korea- Republic Of;IBD Research Group in Korean Association for the Study of the Intestinal Diseases (KASID)
P369: Do teenager and adult onset Crohn´s disease patients have different outcomes? A Portuguese cohort studyECCO’23 CopenhagenYear: 2023
Authors: Cerqueira, R.(1)*;Correia, M.(1);Veloso, R.(1);Manso, M.C.(2);
(1)Centro Hospitalar entre Douro e Vouga, Gastroenterology, Santa Maria Feira, Portugal;(2)University Fernando Pessoa- Porto- Portugal & LAQV@REQUIMTE-UP, Biostastistics- Faculty of Health Sciences- FP-ENAS-, Porto, Portugal;
P370: Correlation of the IBD Disk with intestinal ultrasound in patients with inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: KatsarosMD- PhD- Gastroenterologist, M.(1)*;Kalogirou, M.(1);Katsoula, A.(1);Paschos, P.(2);Karabatsou, S.(1);Tsionis, T.(1);Soufleris, K.(3);Giouleme, O.(1);
(1)Hippokration Hospital, Gastroenterology Division- Second Propaedeutic Department of Internal Medicine- Medical School- Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)"Papageorgiou" Hospital, First Department of Internal Medicine, Thessaloniki, Greece;(3)Theagenion Anticancer Hospital of Thessaloniki, Gastroenterology Department, Thessaloniki, Greece;
P371: Assessment Of Postoperative Complications Following Ileocecal Resection In Crohn's Disease From A Low-To-Middle Income CountryECCO’23 CopenhagenYear: 2023
Authors: Benammi, S.(1)*;Naddouri, J.(1);Bakkali, Y.(1);Alaoui, M.(1);Sebbah, F.(1);Raiss, M.(1);Hrora, A.(1);
(1)University Mohamed V, General Surgery C, Rabat, Morocco;
P372: Endoscopic ultrasonography in the differential diagnosis of Ulcerative colitis and Crohn's disease.ECCO’23 CopenhagenYear: 2023
Authors: BelousovaHead of Gastroenterology Clinic and IBD, E.(1)*;
(1)Moscow Regional Research Clinical Institute named after Vladimirskiy, Gastroenterology, Moscow, Russian Federation;Author(s): Budzinskay A.2 Belousova E.1 Lomakina E.1 Levitskaya A.1 Institute(s): 1Moscow Regional Research and Clinical Institute (MONIKI) Department of Gastroenterology Moscow Russian Federation 2 Moscow Regional Research and Clinical Institute (MONIKI) Department of Endoscopy Moscow Russian Federation Budzinskay A. MD PhD Senior Researcher Belousova E. MD PhD Professor Lomakina E. MD Researcher Levitskaya A. phD candidate
P374: Therapeutic drug monitoring can guide the intravenous-to-subcutaneous switch of infliximab and vedolizumab: a pharmacokinetic simulation studyECCO’23 CopenhagenYear: 2023
Authors: Wang, Z.(1)*;Verstockt , B.(2,3);Sabino , J.(2,3);Ferrante , M.(2,3);Vermeire , S.(2,3);Dreesen, E.(1);
(1)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(2)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
P375: Izencitinib induction treatment in patients with moderately-to-severely-active Crohn's Disease: A phase 2 double-blind, randomized, placebo-controlled studyECCO’23 CopenhagenYear: 2023
Authors: Schreiber, S.(1);Reinisch, W.(2);Nguyen, D.(3);Guerin, T.(4);Kierkus, J.(5);Rozpondek, P.(6);Bourdet, D.(7);Abhyankar, B.(8)*;Peyrin-Biroulet, L.(9);
(1)University Hospital Schleswig-Holstein- Kiel University- Kiel, Department of Internal Medicine I, Kiel, Germany;(2)Medical University of Vienna, Department Internal Medicine III, Vienna, Austria;(3)Former employee of Theravance Biopharma Inc, Research & Development, South San Francisco, United States;(4)Theravance Biopharma Ireland Ltd, Research & Development, Dublin, Ireland;(5)The Children's Memorial Health Institute- Warsaw- Poland, Department of Gastroenterology, Warsaw, Poland;(6)Krakow Medical Center, Krakow Medical Center, Krakow, Poland;(7)Theravance Biopharma Inc., Research and Development, South San Francisco, United States;(8)Former Employee- Theravance Biopharma Ireland Ltd, Clinical Development, Dublin, Ireland;(9)Nancy University Hospital- University of Lorraine- Vandoeuvre-lès-Nancy- France., Department of Gastroenterology, Vandoeuvre-lès-Nancy, France;
P376: Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysisECCO’23 CopenhagenYear: 2023
Authors: Sands, B.E.(1)*;Jain, A.(2);Ahmad, H.A.(2);Osterman, M.(2);Memaj, A.(2);Canavan, J.B.(2);Axelrad, J.E.(3);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(2)Bristol Myers Squibb, Clinical Research, Princeton, United States;(3)NYU Grossman School of Medicine, Medicine, New York, United States;
P377: Changes over time in the Lémann Index and the Inflammatory Bowel Disease-Disability Index in patients with Crohn's diseaseECCO’23 CopenhagenYear: 2023
Authors: Wils, P.(1)*;Cartier, L.(2);Azahaf, M.(3);Hambli, S.(1);Branche, J.(1);Gérard, R.(1);Desreumaux, P.(1);Louvet, A.(1);Nachury, M.(1);
(1)Lille University Hospital, Gastroenterology Department, Lille, France;(2)Douai Hospital, Gastroenterology Department, Douai, France;(3)GHICL, Radiology Department, Lille, France;
P378: Pharmacokinetics of Vedolizumab and Ustekinumab in pregnant women with Inflammatory Bowel Disease and their infants exposed in-uteroECCO’23 CopenhagenYear: 2023
Authors: Prentice, R.(1)*;Flanagan, E.(2);Wright, E.K.(2);Gibson, P.R.(3);Rosella, S.(3);Rosella, O.(3);Goldberg, R.(1);Prideaux, L.(4);Kiburg, K.(5);Ross, A.L.(2);Burns, M.(1);Bell, S.J.(4);
(1)Monash Health, Gastroenterology, Melbourne, Australia;(2)St Vincent's Hospital Melbourne, Gastroenterology, Melbourne, Australia;(3)Monash University, Department of Medicine, Melbourne, Australia;(4)Monash Health, Gastroenterology, Clayton, Australia;(5)University of Melbourne, Department of Medicine, Melbourne, Australia;Pregnancy in Crohn's and Colitis: Observations Levels and Outcomes Extension (PICCOLO-X) Study Group
P379: Effect of upadacitinib on inflammatory markers and clinical outcomes in patients with Crohn's disease in the phase 3, U-EXCEL, U-EXCEED, and U-ENDURE studiesECCO’23 CopenhagenYear: 2023
Authors: Vermeire, S.(1)*;Danese, S.(2,3);Cohen, B.L.(4);Magro, F.(5);Chen, Y.(6);Ha, C.(7);Dubcenco, E.(8);Lacerda, A.P.(8);Marced, E.(8);Oomen, J.(8);Garrison, A.(8);Peyrin-Biroulet, L.(9);
(1)University Hospitals of Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(2)IRCCS San Raffaele Hospital, Department of Gastroenterology and Endoscopy, Milan, Italy;(3)Vita-Salute San Raffaele University, Gastroenterology, Milan, Italy;(4)Digestive Disease and Surgery Institute- Cleveland Clinic, Department of Gastroenterology- Hepatology- & Nutrition, Cleveland, United States;(5)University of Porto, Department of Biomedicine- Unit of Pharmacology and Therapeutics, Porto, Portugal;(6)The Second Affiliated Hospital of Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China;(7)Mayo Clinic, Division of Gastroenterology and Hepatology, Scottsdale, United States;(8)AbbVie Inc., Research and Development, North Chicago, United States;(9)Nancy University Hospital- University of Lorraine, Department of Gastroenterology and Inserum NGERE, Vandoeuvre-lès-Nancy, France;
